Diaverum is the largest independent dialysis clinic operator in Europe with ancillary businesses in South America and Australia. Headquartered in Sweden, it has c.329 clinics in 19 countries.
|Aquisition||2007||Taille des opérations||N/D|
Originally part of a larger quoted medical technology group, Diaverum was identified as a non-core asset when Bridgepoint acquired the business. The company treats patients suffering from end stage renal disease who must undergo dialysis (on average 150 treatments a year) to eliminate toxins and fluids arising from failing kidney function. The company operates in a sector with attractive long-term market dynamics where the number of patients requiring dialysis treatment is growing by 5-7% p.a due to ageing populations and increasing incidence of chronic kidney failure.
To learn more about the company, visit www.diaverum.com